Sharlin Consulting
  • Home
  • About / CV
  • Cases
  • Testimonials
  • Data Integrity
  • My 40 Classes
  • Contact Me
  • BLOG
  • Cell: 410.231.8900
Select Page

FDA and DEA Litigation Briefing

by Josh Sharlin | Jan 11, 2019 | FDA and DEA Litigation Briefing, FDA Expert Witness

Download Article Medical Devices: Individual Liability and MDR ReportingUnited States v. Olympus Medical Systems Corp. and Yabe Plea Agreements, No. 2:18-cr-00727 (D.N.J. filed Dec. 10, 2018) This set of plea agreements initiated from a company’s failure to file...

FDA’s Requirements for Financial Disclosure

by Josh Sharlin | Jan 8, 2019 | FDA Regulatory, FDA’s Requirements for Financial Disclosure

Download Slides from Presentation A detailed description of FDA requirements for financial disclosure by clinical investigators. The content includes; 1) Five key definitions, 2) Five significant penalties for noncompliance, 3) Dollar thresholds that trigger reporting...

Recent Posts

  • What Needs to be in an FDA Product Submission: A Reviewer’s Perspective
  • FDA and DEA Litigation Briefing
  • FDA’s Requirements for Financial Disclosure

Archives

  • December 2020
  • January 2019

Categories

  • FDA and DEA Litigation Briefing
  • FDA Expert Witness
  • FDA Regulatory
  • FDA’s Requirements for Financial Disclosure
  • What Needs to be in an FDA Product Submission: A Reviewer’s Perspective

Tags

DEA DEA Litigation Briefing FDA FDA and DEA Litigation Briefing FDA Financial Disclosure fda Litigation Briefing FDA Product Submission FDA’s Requirements Financial Disclosure
  • Facebook

Sharlin Consulting ©2020 | Designed by Advantage Media Partners